Varex Imaging (VREX) Projected to Post Quarterly Earnings on Thursday

Varex Imaging (NASDAQ:VREX) is expected to be issuing its Q2 2025 quarterly earnings data after the market closes on Thursday, May 8th. Analysts expect Varex Imaging to post earnings of $0.14 per share and revenue of $206.76 million for the quarter. Varex Imaging has set its Q2 2025 guidance at 0.050-0.200 EPS.

Varex Imaging (NASDAQ:VREX) last released its quarterly earnings results on Thursday, February 6th. The company reported $0.07 earnings per share for the quarter, topping the consensus estimate of $0.04 by $0.03. Varex Imaging had a negative net margin of 5.79% and a positive return on equity of 4.00%. On average, analysts expect Varex Imaging to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Varex Imaging Price Performance

NASDAQ:VREX opened at $8.26 on Wednesday. Varex Imaging has a 52-week low of $6.97 and a 52-week high of $16.93. The stock has a fifty day moving average of $10.16 and a 200 day moving average of $12.81. The company has a debt-to-equity ratio of 1.02, a quick ratio of 2.50 and a current ratio of 4.36. The firm has a market capitalization of $340.31 million, a price-to-earnings ratio of -7.06 and a beta of 0.62.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Oppenheimer lowered their target price on shares of Varex Imaging from $30.00 to $23.00 and set an “outperform” rating on the stock in a research note on Friday, February 7th. B. Riley restated a “buy” rating and set a $22.00 price objective (up previously from $21.00) on shares of Varex Imaging in a research report on Friday, February 7th. Finally, StockNews.com upgraded shares of Varex Imaging from a “hold” rating to a “buy” rating in a research report on Friday, February 7th.

Insider Buying and Selling at Varex Imaging

In other Varex Imaging news, SVP Kimberley E. Honeysett sold 4,007 shares of the business’s stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $12.81, for a total value of $51,329.67. Following the completion of the sale, the senior vice president now directly owns 4,002 shares of the company’s stock, valued at $51,265.62. The trade was a 50.03 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Sunny Sanyal sold 8,749 shares of Varex Imaging stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $11.24, for a total value of $98,338.76. Following the completion of the transaction, the chief executive officer now owns 190,193 shares in the company, valued at approximately $2,137,769.32. This represents a 4.40 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 4.30% of the company’s stock.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.